MEN-2501

N/A

Report date: 2026/02/03 10:15:46
NME

Base Information

Drug NameMEN-2501
Drug Alias NameMEN2501MEN-2501ISM9682ISM-9682
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKinesin-like protein KIF18A inhibitors
TargetsKinesin-like protein KIF18A
Therapy Area/IndicationsSolid tumoursOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInsilico Medicine Ltd
China Registration ClassN/A

Develop Information

Active CompaniesStemline Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A